Serologic evaluation, efficacy, and safety of a commercial modified-live canine distemper vaccine in domestic ferrets

Jeffrey Wimsatt, Michele T Jay-Russell, Kim E. Innes, Michael Jessen, James K. Collins

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective - To determine efficacy and safety of a commercial modified-live canine distemper virus (CDV) vaccine used for prophylaxis in domestic ferrets. Animals - Sixteen 16-week-old neutered male ferrets. Procedures - Equal groups of ferrets were inoculated subcutaneously at 16 and 20 weeks of age with saline (0.9% NaCI) solution or a vaccine derived from the Onderstepoort CDV strain and attenuated in a primate cell line. Live virulent CDV was administered to all ferrets intranasally and orally 3 weeks after the second inoculation. Clinical signs and body weights were monitored regularly during the study. Blood samples for serologic examination were drawn prior to each inoculation, before challenge exposure, and 10, 15, and 21 days after exposure. Blood samples for reverse transcriptase polymerase chain reaction (RT-PCR) were obtained 5 days after the first vaccination, and 5, 10, 15, and 21 days after challenge exposure. Results - After challenge exposure, control ferrets had significantly more clinical signs and weight loss, compared with vaccinates. All vaccinated ferrets survived, whereas all control ferrets died. The RT-PCR assay was successful in detecting CDV in blood and fresh or formalin-fixed tissues from infected ferrets. Conclusions and Clinical Relevance - Findings suggest that the vaccine when given SC to domestic ferrets as directed is safe and protective against challenge exposure with virurent CDV. The RT-PCR assay may simplify detection of CDV in fresh and fixed tissues.

Original languageEnglish (US)
Pages (from-to)736-740
Number of pages5
JournalAmerican Journal of Veterinary Research
Volume62
Issue number5
StatePublished - May 2001
Externally publishedYes

Fingerprint

Distemper
canine distemper
Ferrets
ferrets
Canine Distemper Virus
Canine distemper virus
Vaccines
vaccines
Safety
Reverse Transcriptase Polymerase Chain Reaction
reverse transcriptase polymerase chain reaction
vaccination
blood
assays
formalin
Primates
Formaldehyde
Weight Loss
disease control
Vaccination

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Serologic evaluation, efficacy, and safety of a commercial modified-live canine distemper vaccine in domestic ferrets. / Wimsatt, Jeffrey; Jay-Russell, Michele T; Innes, Kim E.; Jessen, Michael; Collins, James K.

In: American Journal of Veterinary Research, Vol. 62, No. 5, 05.2001, p. 736-740.

Research output: Contribution to journalArticle

@article{4067bce8cb3e4213aad76366ffd41b7c,
title = "Serologic evaluation, efficacy, and safety of a commercial modified-live canine distemper vaccine in domestic ferrets",
abstract = "Objective - To determine efficacy and safety of a commercial modified-live canine distemper virus (CDV) vaccine used for prophylaxis in domestic ferrets. Animals - Sixteen 16-week-old neutered male ferrets. Procedures - Equal groups of ferrets were inoculated subcutaneously at 16 and 20 weeks of age with saline (0.9{\%} NaCI) solution or a vaccine derived from the Onderstepoort CDV strain and attenuated in a primate cell line. Live virulent CDV was administered to all ferrets intranasally and orally 3 weeks after the second inoculation. Clinical signs and body weights were monitored regularly during the study. Blood samples for serologic examination were drawn prior to each inoculation, before challenge exposure, and 10, 15, and 21 days after exposure. Blood samples for reverse transcriptase polymerase chain reaction (RT-PCR) were obtained 5 days after the first vaccination, and 5, 10, 15, and 21 days after challenge exposure. Results - After challenge exposure, control ferrets had significantly more clinical signs and weight loss, compared with vaccinates. All vaccinated ferrets survived, whereas all control ferrets died. The RT-PCR assay was successful in detecting CDV in blood and fresh or formalin-fixed tissues from infected ferrets. Conclusions and Clinical Relevance - Findings suggest that the vaccine when given SC to domestic ferrets as directed is safe and protective against challenge exposure with virurent CDV. The RT-PCR assay may simplify detection of CDV in fresh and fixed tissues.",
author = "Jeffrey Wimsatt and Jay-Russell, {Michele T} and Innes, {Kim E.} and Michael Jessen and Collins, {James K.}",
year = "2001",
month = "5",
language = "English (US)",
volume = "62",
pages = "736--740",
journal = "American Journal of Veterinary Research",
issn = "0002-9645",
publisher = "American Veterinary Medical Association",
number = "5",

}

TY - JOUR

T1 - Serologic evaluation, efficacy, and safety of a commercial modified-live canine distemper vaccine in domestic ferrets

AU - Wimsatt, Jeffrey

AU - Jay-Russell, Michele T

AU - Innes, Kim E.

AU - Jessen, Michael

AU - Collins, James K.

PY - 2001/5

Y1 - 2001/5

N2 - Objective - To determine efficacy and safety of a commercial modified-live canine distemper virus (CDV) vaccine used for prophylaxis in domestic ferrets. Animals - Sixteen 16-week-old neutered male ferrets. Procedures - Equal groups of ferrets were inoculated subcutaneously at 16 and 20 weeks of age with saline (0.9% NaCI) solution or a vaccine derived from the Onderstepoort CDV strain and attenuated in a primate cell line. Live virulent CDV was administered to all ferrets intranasally and orally 3 weeks after the second inoculation. Clinical signs and body weights were monitored regularly during the study. Blood samples for serologic examination were drawn prior to each inoculation, before challenge exposure, and 10, 15, and 21 days after exposure. Blood samples for reverse transcriptase polymerase chain reaction (RT-PCR) were obtained 5 days after the first vaccination, and 5, 10, 15, and 21 days after challenge exposure. Results - After challenge exposure, control ferrets had significantly more clinical signs and weight loss, compared with vaccinates. All vaccinated ferrets survived, whereas all control ferrets died. The RT-PCR assay was successful in detecting CDV in blood and fresh or formalin-fixed tissues from infected ferrets. Conclusions and Clinical Relevance - Findings suggest that the vaccine when given SC to domestic ferrets as directed is safe and protective against challenge exposure with virurent CDV. The RT-PCR assay may simplify detection of CDV in fresh and fixed tissues.

AB - Objective - To determine efficacy and safety of a commercial modified-live canine distemper virus (CDV) vaccine used for prophylaxis in domestic ferrets. Animals - Sixteen 16-week-old neutered male ferrets. Procedures - Equal groups of ferrets were inoculated subcutaneously at 16 and 20 weeks of age with saline (0.9% NaCI) solution or a vaccine derived from the Onderstepoort CDV strain and attenuated in a primate cell line. Live virulent CDV was administered to all ferrets intranasally and orally 3 weeks after the second inoculation. Clinical signs and body weights were monitored regularly during the study. Blood samples for serologic examination were drawn prior to each inoculation, before challenge exposure, and 10, 15, and 21 days after exposure. Blood samples for reverse transcriptase polymerase chain reaction (RT-PCR) were obtained 5 days after the first vaccination, and 5, 10, 15, and 21 days after challenge exposure. Results - After challenge exposure, control ferrets had significantly more clinical signs and weight loss, compared with vaccinates. All vaccinated ferrets survived, whereas all control ferrets died. The RT-PCR assay was successful in detecting CDV in blood and fresh or formalin-fixed tissues from infected ferrets. Conclusions and Clinical Relevance - Findings suggest that the vaccine when given SC to domestic ferrets as directed is safe and protective against challenge exposure with virurent CDV. The RT-PCR assay may simplify detection of CDV in fresh and fixed tissues.

UR - http://www.scopus.com/inward/record.url?scp=0035036044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035036044&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 736

EP - 740

JO - American Journal of Veterinary Research

JF - American Journal of Veterinary Research

SN - 0002-9645

IS - 5

ER -